Literature DB >> 21461944

Fluconazole-, amphotericin-B-, caspofungin-, and anidulafungin-resistant Candida ciferrii: an unknown cause of systemic mycosis in a child.

Hasan Agın1, Yüce Ayhan, Ilker Devrim, Gamze Gülfidan, Sener Tulumoglu, Ertan Kayserili.   

Abstract

Candida ciferrii, which is known as an agent of superficial yeast infection and onychomycosis, has rarely been isolated as an agent of candidemia. Limited reports have suggested different patterns of antifungal sensitivity. We report a rare candidemia case caused by c.ciferrii in an 8-year-old child in which isolated candida species were resistant to amphotericin-B (MIC > 1 μg/ml), fluconazole, (MIC ≥ 64 μg/ml), caspofungin (MIC ≥ 32 μg/ml), and anidulafungin (MIC ≥ 32 μg/ml) but sensitive to voriconazole (MIC ≤ 0.12 μg/ml). As far as we aware, this was the first recorded C. ciferrii candidemia case in children.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21461944     DOI: 10.1007/s11046-011-9418-6

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  15 in total

1.  Candida ciferrii, a new fluconazole-resistant yeast causing systemic mycosis in immunocompromised patients.

Authors:  E Gunsilius; C Lass-Flörl; C M Kähler; G Gastl; A L Petzer
Journal:  Ann Hematol       Date:  2001-03       Impact factor: 3.673

2.  Prevalence of Candida ciferrii in elderly patients with trophic disorders of the legs.

Authors:  L de Gentile; J P Bouchara; C Le Clec'h; B Cimon; F Symoens; D Chabasse
Journal:  Mycopathologia       Date:  1995-08       Impact factor: 2.574

3.  Candida ciferrii, a new yeast species.

Authors:  N J Kreger-Van Rij
Journal:  Mycopathol Mycol Appl       Date:  1965-06-15

4.  Voriconazole activity against clinical yeast isolates: a multicentre Italian study.

Authors:  Giulia Morace; Luciano Polonelli
Journal:  Int J Antimicrob Agents       Date:  2005-09       Impact factor: 5.283

5.  In vitro susceptibility of Candida species to five antifungal agents in a German university hospital assessed by the reference broth microdilution method and Etest.

Authors:  Ralf Fleck; Annebärbel Dietz; Herbert Hof
Journal:  J Antimicrob Chemother       Date:  2007-02-09       Impact factor: 5.790

6.  Geographic variation in the susceptibilities of invasive isolates of Candida glabrata to seven systemically active antifungal agents: a global assessment from the ARTEMIS Antifungal Surveillance Program conducted in 2001 and 2002.

Authors:  M A Pfaller; S A Messer; L Boyken; S Tendolkar; R J Hollis; D J Diekema
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

7.  Increasing incidence of candidemia: results from a 20-year nationwide study in Iceland.

Authors:  Lena Rós Asmundsdóttir; Helga Erlendsdóttir; Magnús Gottfredsson
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

8.  Distribution and antifungal susceptibility of Candida species causing candidemia from 1996 to 1999.

Authors:  Ming-Fang Cheng; Kwok-Woon Yu; Ran-Bin Tang; Yu-Hua Fan; Yun-Liang Yang; Kai-Sheng Hsieh; Monto Ho; Hsiu-Jung Lo
Journal:  Diagn Microbiol Infect Dis       Date:  2004-01       Impact factor: 2.803

9.  Candida ciferrii and Candida chiropterorum isolated from clinical specimens.

Authors:  R M Furman; D G Ahearn
Journal:  J Clin Microbiol       Date:  1983-11       Impact factor: 5.948

10.  A retrospective analysis of antifungal susceptibilities of Candida bloodstream isolates from Singapore hospitals.

Authors:  Thean Yen Tan; Ai Ling Tan; Nancy W S Tee; Lily S Y Ng
Journal:  Ann Acad Med Singapore       Date:  2008-10       Impact factor: 2.473

View more
  6 in total

1.  First isolation of the Stephanoascus ciferrii in feline otitis in Brazil.

Authors:  Angelita dos Reis Gomes; Ângela Leitzke Cabana; Luiza da Gama Osório; Rosema Santin; Isabel Duarte Schuch; Emanoele Figueiredo Serra; Patrícia Silva Nascente; Mário Carlos Araújo Meireles
Journal:  Braz J Microbiol       Date:  2014-10-09       Impact factor: 2.476

2.  A new approach by optical coherence tomography for elucidating biofilm formation by emergent Candida species.

Authors:  Melyna Chaves Leite de Andrade; Marcos Andre Soares de Oliveira; Franz de Assis Graciano Dos Santos; Pamella de Brito Ximenes Vilela; Michellangelo Nunes da Silva; Danielle Patrícia Cerqueira Macêdo; Reginaldo Gonçalves de Lima Neto; Henrique Jonh Pereira Neves; Ildnay de Souza Lima Brandão; Guilherme Maranhão Chaves; Renato Evangelista de Araujo; Rejane Pereira Neves
Journal:  PLoS One       Date:  2017-11-16       Impact factor: 3.240

3.  Prevalence and Antifungal Susceptibility of Clinically Relevant Candida Species, Identification of Candida auris and Kodamaea ohmeri in Bangladesh.

Authors:  Fardousi Akter Sathi; Shyamal Kumar Paul; Salma Ahmed; Mohammad Monirul Alam; Syeda Anjuman Nasreen; Nazia Haque; Arup Islam; Sultana Shabnam Nila; Sultana Zahura Afrin; Meiji Soe Aung; Nobumichi Kobayashi
Journal:  Trop Med Infect Dis       Date:  2022-08-26

4.  Microbial survey of the mummies from the Capuchin Catacombs of Palermo, Italy: biodeterioration risk and contamination of the indoor air.

Authors:  Guadalupe Piñar; Dario Piombino-Mascali; Frank Maixner; Albert Zink; Katja Sterflinger
Journal:  FEMS Microbiol Ecol       Date:  2013-07-09       Impact factor: 4.194

5.  Azole-resistant Candida blankii as a newly recognized cause of bloodstream infection.

Authors:  A Al-Haqqan; N Al-Sweih; S Ahmad; S Khan; L Joseph; S Varghese; Z Khan
Journal:  New Microbes New Infect       Date:  2018-06-23

6.  Identification and Antifungal Susceptibility Analysis of Stephanoascus ciferrii Complex Species Isolated From Patients With Chronic Suppurative Otitis Media.

Authors:  Penghao Guo; Zhongwen Wu; Pingjuan Liu; Yili Chen; Kang Liao; Yaqin Peng; Yuting He
Journal:  Front Microbiol       Date:  2021-07-21       Impact factor: 5.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.